Literature DB >> 9393846

Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants.

X Zhang1, S M Kelly, W S Bollen, R Curtiss.   

Abstract

S. typhimurium SL1344 and UK-1 mutants with deletions of the crp (cyclic AMP receptor protein) and cdt (colonization of deep tissues) genes have been constructed and characterized, and their levels of virulence and immunogenicity have been determined for BALB/c mice. All Crp- Cdt- and Crp+ Cdt- mutants were avirulent, as mice survived oral doses of 10(9) cells without illness. All the mutants colonized the gut-associated lymphoid tissue efficiently, but capacities to colonize deeper tissues, such as those of the spleen and liver, and blood were significantly reduced for the Crp- Cdt- and Crp+ Cdt- mutants compared with the Crp- Cdt+ mutant and the wild-type parent strain. The Crp- Cdt- and Crp+ Cdt- SL1344 strains induced complete protection, as all mice immunized with the mutants survived challenge with approximately 10(4) times the 50% lethal dose of the wild-type SL1344 strain. The Crp- UK-1 strain was least attenuated yet induced the highest level of protective immunity against challenge with the wild-type UK-1 strain. The Crp+ Cdt- and Crp- Cdt- strains, although totally attenuated, differed in immunogenicity to challenge with the highly virulent UK-1 parent, with the apparently hyperattenuated Crp- Cdt- strain inducing a lower level of protective immunity than the Crp+ Cdt- strain. Nevertheless, these UK-1 Crp- Cdt- and Crp+ Cdt- strains induced complete protective immunity to challenge with the less-virulent SL1344 wild-type strain. Taken collectively, the results indicate that the attenuation of a highly virulent S. typhimurium strain can yield a vaccine that induces excellent protective immunity to challenge with less-virulent S. typhimurium strains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393846      PMCID: PMC175779          DOI: 10.1128/iai.65.12.5381-5387.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  The role of cAMP in flagellation of Salmonella typhimurium.

Authors:  Y Komeda; H Suzuki; J I Ishidsu; T Iino
Journal:  Mol Gen Genet       Date:  1976-12-31

2.  Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the peyer's patches, mesenteric lymph nodes and other lymphoid tissues.

Authors:  G L Asherson; M Zembala; M A Perera; B Mayhew; W R Thomas
Journal:  Cell Immunol       Date:  1977-09       Impact factor: 4.868

3.  Tandem chromosomal duplications in Salmonella typhimurium: fusion of histidine genes to novel promoters.

Authors:  R P Anderson; J R Roth
Journal:  J Mol Biol       Date:  1978-02-15       Impact factor: 5.469

4.  Phage P22-mutants with increased or decreased transduction abilities.

Authors:  H Schmieger
Journal:  Mol Gen Genet       Date:  1972

Review 5.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

6.  Selection for loss of tetracycline resistance by Escherichia coli.

Authors:  S R Maloy; W D Nunn
Journal:  J Bacteriol       Date:  1981-02       Impact factor: 3.490

7.  Origin and differentiation of lymphocytes involved in the secretory IgA responses.

Authors:  J J Cebra; P J Gearhart; R Kamat; S M Robertson; J Tseng
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

8.  A common mucosal immunologic system involving the bronchus, breast and bowel.

Authors:  J Bienenstock; M McDermott; D Befus; M O'Neill
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

9.  Requirement of adenosine 3', 5'-cyclic phosphate for flagella formation in Escherichia coli and Salmonella typhimurium.

Authors:  T Yokota; J S Gots
Journal:  J Bacteriol       Date:  1970-08       Impact factor: 3.490

10.  The route of enteric infection in normal mice.

Authors:  P B Carter; F M Collins
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  37 in total

1.  Construction of in-frame aroA deletion mutants of Mannheimia haemolytica, Pasteurella multocida, and Haemophilus somnus by using a new temperature-sensitive plasmid.

Authors:  Fred M Tatum; Robert E Briggs
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

Review 2.  Live attenuated vaccines for invasive Salmonella infections.

Authors:  Sharon M Tennant; Myron M Levine
Journal:  Vaccine       Date:  2015-04-19       Impact factor: 3.641

Review 3.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

4.  Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

Authors:  Sharon M Tennant; Jin-Yuan Wang; James E Galen; Raphael Simon; Marcela F Pasetti; Orit Gat; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

5.  Identification and characterization of a novel flagellum-dependent Salmonella-infecting bacteriophage, iEPS5.

Authors:  Younho Choi; Hakdong Shin; Ju-Hoon Lee; Sangryeol Ryu
Journal:  Appl Environ Microbiol       Date:  2013-06-07       Impact factor: 4.792

6.  Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines.

Authors:  Tie Liu; Rolf König; Jian Sha; Stacy L Agar; Chien-Te K Tseng; Gary R Klimpel; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-06       Impact factor: 3.738

7.  Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium.

Authors:  Chang-Ho Baek; Shifeng Wang; Kenneth L Roland; Roy Curtiss
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

8.  Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Authors:  Wei Xin; Soo-Young Wanda; Yuhua Li; Shifeng Wang; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice.

Authors:  Bronwyn M Gunn; Soo-Young Wanda; Dana Burshell; Caihong Wang; Roy Curtiss
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

10.  Mutations in the Salmonella enterica serovar Choleraesuis cAMP-receptor protein gene lead to functional defects in the SPI-1 Type III secretion system.

Authors:  Zeng-Weng Chen; Shih-Ling Hsuan; Jiunn-Wang Liao; Ter-Hsin Chen; Chi-Ming Wu; Wei-Cheng Lee; Cheng-Chung Lin; Chih-Ming Liao; Kuang-Sheng Yeh; James R Winton; Chienjin Huang; Maw-Sheng Chien
Journal:  Vet Res       Date:  2009-09-24       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.